Partnerships & Joint Ventures
-
PhoreMost and Sentinel extend cancer collaboration
PhoreMost, the Cambridge biopharma company dedicated to drugging ‘undruggable’ disease targets, and Sentinel Oncology, have expanded a collaboration... Read More
-
Sphere Fluidics hits a fresh Peak with cell analysis collaboration
Sphere Fluidics, which is commercialising single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and... Read More
-
Qualcomm and Tencent form digital entertainment alliance
Two global influencers with major investment in China as well as the Cambridge technology cluster have formed a strategic collaboration designed to... Read More
-
Astex already cashing in on $16bn market
Cambridge-based Astex Pharmaceuticals, dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of... Read More
-
Foetal attraction as Horizon Discovery leads prenatal testing initiative
Horizon Discovery Group in Cambridge is at the heart of a new alliance developing crucial reference material for non-invasive prenatal testing (NIPT... Read More
-
Abcam forges US alliance with New Jersey contract research organisation
Abcam, the Cambridge life science reagents and tools specialist has unveiled a key collaboration with a US partner. It has teamed with Visikol, a... Read More
-
Quadram Institute in alliance to tackle global food and health challenges
Quadram Institute Bioscience at Norwich Research Park and the University of Newcastle in Australia have signed a Memorandum of Understanding to... Read More
-
PragmatIC and German ally form RFID partnership
Cambridge-based PragmatIC, a pioneer in ultra-low cost flexible electronics, and German powerhouse Mühlbauer, a proven technology supplier of RFID... Read More
-
Rothamsted and Cranfield help drive Morocco AgriTech project
An international academic partnership has been announced by Mohammed VI Polytechnic University in Morocco and two of the East of England and UK’s... Read More
-
Abcam helping to develop research tools for major deficiency disorder
Cambridge antibody technology from Abcam is at the heart of a UK partnership designed to develop solutions to fight a serious deficiency disorder... Read More
-
Horizon clinches gamechanging cell therapy alliance with US university
A collaboration between Cambridge-based gene editing world leader Horizon Discovery and Rutgers – the state university of New Jersey – promises to... Read More
-
Horizon alliance seeks fresh drugs to treat lung and colorectal cancer
Cambridge-based gene editing world leader Horizon Discovery has struck an exclusive target discovery partnership with fellow AIM company C4X... Read More
-
Cambridge China Centre and BID join forces to fuel East meets East opportunity
Cambridge China Centre and Cambridge Business Improvement District (BID) have formed a strategic partnership to drive forward UK|China relationships... Read More
-
Cambridge alliance to fast-track drug discovery
Cambridge neighbours PhoreMost and o2h discovery have joined forces to accelerate the progress of drug discovery programmes. PhoreMost is a... Read More
-
Abcam alliance with Chinese diagnostics leader
Abcam, the Cambridge innovator in reagents and research tools, has joined forces with a Chinese based diagnostics company to develop novel companion... Read More
-
Objective is AI success in any language
Chelmsford-based software firm, Objective IT is joining forces with University of Essex researchers to create two new Artificial Intelligence (AI)... Read More
-
Arm and PragmatIC in smart packaging superchip drive
A new type of highly flexible ‘superchips’ are being developed in a three-way UK partnership involving Cambridge technology front runners Arm and... Read More
-
Mobas teams with CrowdCat in consumer behaviour initiative
Mobas, the brand transformation agency, has announced a partnership with fellow Cambridge-based company CrowdCat to provide clients with ground-... Read More
-
Partners using AI and machine learning for drug discovery
LifeArc®, the UK-based medical research charity, and the Milner Therapeutics Institute at Cambridge University have formed an alliance to use... Read More
-
Cypralis and Gilead expand drug discovery collaboration
Cambridge life science companies Cypralis and Gilead Sciences, Inc. have stepped up a drug development collaboration targeting acute and chronic... Read More